After a shaky mid-week dip, the AIM All-Share index ended the week 0.5pc higher, closing at 769.74 following a late rally. The FTSE 100 closed Friday’s session down 14 points at 9,283, easing back from recent gains but still hovering close to record territory. The dip came despite the release of downbeat economic data earlier in the day.
ImmuPharma (LON: IMM) has lit up the market, with its shares soaring 572% over the past month.
The rally began in late August but really took off on 1 September, when the company announced the filing of a new patent for its lead drug, P140. At first glance, the update looked fairly routine. Digging deeper, though, the detail suggests ImmuPharma may be sitting on something far more significant — a development that has investors piling in.
Tim McCarthy, CEO of Immupharma, said,” With regards to deals with big pharma: “But we’re not at a standing start here. You know, we’ve got relationships already with a number of these companies. And I’ve been pleasantly surprised by, you know, the very very positive response and reactions, you know, even in the last week since we put the PATENT notice out. So yes, we’ve laid that out in the beginning of this year. So shareholders of IMM should certainly expect a deal or deals in the plural between now and year end and frankly those deals could happen at any time between now and year end. But that’s the space we’ve given ourselves to get some deals done by the end of this year.”
Investor optimism is running high, with shares rocketing on hopes that P140 could succeed where other treatments have failed. The stock finished the week up 138pc.
Shares in 80 Mile (LON: 80M) surged 50% after Pelican Acquisition Corporation’s merger deal implied a $92 million valuation for the company’s retained 30% interest in the Jameson hydrocarbon project in Greenland.
The valuation underscores rising investor optimism ahead of the project’s long-anticipated drilling campaign.
Rockfire Resources (LON:ROCK) shares surged 48pc after the company confirmed that diamond drilling has commenced at its Molaoi zinc project in Greece. The 10,000-metre programme is designed to upgrade existing resources and assess the project’s germanium potential. Management said investors can expect a steady flow of updates as the campaign continues into early 2026.
SEEEN (LON:SEEN) shares resumed trading following the release of the company’s 2024 accounts, with revenues up 48% at £3m and a loss of £1.6m. Interim results are expected in the coming weeks and could point to a narrowing loss. For 2025, forecasts suggest revenues of £5m with a reduced loss of £600,000. The stock rebounded 28.6% on its return, closing at 4.5p.
Red Rock Resources (LON:RRR) has agreed to sell its gold royalty over production from the El Limon mine in Colombia back to the mine’s owner for £1m. As part of the deal, the company will also receive 200,000 subscription rights for Soma Gold Corp shares, exercisable at C$2 each. The royalty had not generated any income. Shares in Red Rock rose 16.2pc to 57.5p following the announcement.
Roadside Real Estate (LON:ROAD) has announced plans to sell its commercial property business to Tancourt, a company controlled by chief executive Charles Dickson and his family, in a £12m deal. After accounting for debt and other liabilities, net proceeds of £4.7m will be received. The transaction, priced above market valuation, is expected to streamline Roadside’s operations. Shares in Roadside Real Estate rose 3.7pc to 56.5p following the news.
Onto the fallers
Shares in ANGLE (LON: AGL) plunged 57pc this week after interim results disappointed investors. On Friday, the company said founder and long-serving chief executive Andrew Newland, along with finance director Ian Griffiths, will step down from the board following discussions with a major shareholder. The company has developed a cancer diagnostic technology.
Finseta (LON:FIN) shares have fallen 37pc this week after the payments group lowered its full-year growth guidance, citing weaker-than-expected US dollar trading. First-half revenue rose 16pc to £5.9m, but earnings declined as the company increased investment in new initiatives. Management said recent expansion efforts should support stronger growth over the medium term.
Big Technologies (LON:BIG) has expanded its legal action against former chief executive Sara Murray and others, alleging forgery and deliberate falsification of documents to enable the company’s AIM flotation, as well as the diversion of £19m from the business. The company said mediation is being offered as a potential route to settlement. It also warned that ongoing Buddi litigation could weigh on its financial health and that it is seeking to recover liabilities from Ms Murray and other parties. Shares in Big Technologies fell 14.7pc to 78p following the update.
Conroy Gold and Natural Resources (LON:CGNR) has announced plans to raise up to £1.5m through a placing at 10p per share. Each share will include a warrant exercisable at 17p, with a four-month restriction period from issue. The fundraising is aimed at attracting North American investors, with proceeds to be used for geological work across the company’s Irish exploration projects. Shares in Conroy Gold fell 6.7pc to 10.5p following the announcement.
